However, the protective/neurotoxic role of fractalkine and its receptor signaling in neurodegenerative disease is an intricate and highly debated research topic and it is becoming even more complicated as new studies reveal conflicting results depending on the CNS insult [72]–[75]. Here, CX3CL1 is linked to neurodegenerative disease.